Company Performance: Merck's financial health, revenue growth, profitability, and pipeline of new drugs significantly influence investor confidence.

Industry Trends: Developments in the pharmaceutical sector, including regulatory changes, competitor activities, and technological advancements, impact the overall outlook.

Economic Conditions: Macroeconomic factors such as interest rates, inflation, and global economic growth can affect investment decisions and overall market sentiment.

Regulatory Environment: Drug approvals, patent expirations, and government policies on healthcare pricing directly impact Merck's revenue streams and profitability.

Market Sentiment: Investor perception, news coverage, and general market optimism or pessimism can drive stock price fluctuations.

Specific News: Announcements regarding clinical trial results, mergers, acquisitions, or collaborations can trigger immediate price reactions.

Global Events: Geopolitical events, pandemics, and other global crises can introduce uncertainty and volatility in the market, affecting stock prices.

Currency Fluctuations: Changes in the exchange rate between the Euro and other major currencies can affect the value of Merck's international sales and profits.

Investor Expectations: Market expectations about Merck's future performance, based on analysts' reports and earnings forecasts, influence buying and selling decisions.